A Ten Year Retrospective Audit of the Clinic-pathological Management and Treatment Outcomes of Patient’s with Nephroblastoma (Wilms Tumor) at Kenyatta National Hospital

P.M Mwamba^1, , E. Rogena¹ and G.W Kitonyi¹

¹Department of Pathology, University of Nairobi, P.O Box 19676 – 00202, Nairobi, Kenya

Cite this paper:
P.M Mwamba, E. Rogena and G.W Kitonyi. A Ten Year Retrospective Audit of the Clinic-pathological Management and Treatment Outcomes of Patient’s with Nephroblastoma (Wilms Tumor) at Kenyatta National Hospital. American Journal of Cancer Prevention. 2017; 5(2):21-24. doi: 10.12691/ajcp-5-2-1

Abstract

Background and aims: Treatment of Nephroblastoma (Wilms’ tumor) in children is one of medicine's success stories. Due to improvements in surgical techniques, drug therapies, and radiation, 85 to 90 percent of children with Wilms tumor who receive state-of-the-art treatment are cured. While this is true for developed countries the outcomes of nephroblastoma (Wilms’ tumor, WT) in our hospital and other developing countries are notably below those in these countries. There are continuous reviews and updates of clinical pathologic features, treatment designs, and treatment outcomes every 2 or 3 years, in the developed countries. However, in resource poor countries, such frequent reviews and updates are presently not affordable but, nevertheless, efforts should be made to undertake them every 5 or so years, to improve patient management and treatment outcomes. The objectives of this study were to review the clinical presentation and management of children with Wilms tumor and the factors influencing the outcome at Kenyatta National Referral and Teaching Hospital (KNH). This was a retrospective descriptive cross-sectional study. Analysis of the data was carried out using the statistical package for the social sciences (SPSS) software. The findings of the study will form a basis for revision of treatment design for patients diagnosed with Nephroblastoma at KNH, and by extension, other tertiary public health care facilities in Kenya. Patients and methods: The records of 140 WT patients, aged less than 16 years, who were treated in Kenyatta National Hospital, Kenya, during the period from January 1997 to December 2008 were reviewed. The management protocol followed the scheme of the US National Wilms Tumor Study Group (NSWTG). Results: Thirteen cases (38.2%) were diagnosed as stage I, 4 (11.8%) as stage II, 13 (38.2%) as stage III and 2 (5.9%) as stage IV. Eight cases had bilateral disease (stage V). Four-year overall survival (OS) and event free survival (EFS) rates were xx% and xx%, respectively. Univariate analysis by Log-rank test revealed statistically significant associations between OS and nodal status (p- value < 0.01), manifestation of gross hematuria (p-value 0.02), and tumor size of 10 centimeters or more (p-value 0.02). Multivariate analysis found only the nodal status to be independently associated with OS at a Hazard Ratio of 16.6 (p-value < 0.01). Eight of 13 stage I cases and 6/13 stage III cases had relapsed, with two-year post-relapse survival of 42.8%. Significantly poorer outcome was found in cases with early relapse within 200 days after enrollment (p-value 0.02). Conclusion: Childhood Wilms’ tumor presents late in our setting with its consequent management challenges. The need to educate the populace and the primary healthcare providers on the benefits of early diagnosis and treatment of this condition cannot be overemphasized. Large tumor size and gross hematuria were associated with risk of a poorer outcome.

Keywords:
nephroblastoma Wilms’ tumor hematuria survival prognosis

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Ekenze SO., Heij HA., Youngson GG.. Kidney tumours in Emmanuel Ameh et al (eds): Paediatric Surgery: A comprehensive Text for Africa. Global-HELP Organization, Seattle, WA, 2011.
[2]	Mitchell C., Jones PM., Kelsey A. et al.. The treatment of Wilms’ tumour: Results of the United Kingdom Children’s Cancer Study .Br J. Cancer, 2000; 83, p 602-608.
[3]	Ekenze SO., Agugua-ObianyoNEN, Odetunde OA. The challenge of nephroblastoma in a developing country. Ann Oncol 2006; 17: p 1598-1600.
[4]	Hadley GP, Naude F. Malignant solid tumour, HIV infection and tuberculosis in children: an unholy triad. Pediatric Surgery International 2009; 25: 697-701.
[5]	Sembulingam K., Sembulingam M.. Cardiac output, in Essentials of Medical physiology, ed 5. New Delhi; Jaypee Brothers Medical Publishers (p) ltd, 2010, p 553.
[6]	Leape LL., Breslow NE.. The surgical treatment of Wilms’ tumour: Results of the National Wilms’ Tumor Study. Ann Surg 1978; 187: p 351-356.
[7]	Tagg EP., Thomas PB,Othersen HB.. Wilms’ tumor in Grosfeld JL et al.(eds): Pediatric Surgery, ed 6. Philadelphia, Mosby Elsevier Yearbook Publishers, 2006, p 445-460.
[8]	Isreals T., Molyneux EM., Caron HN et al. Preoperative chemotherapy for patients with Wilms’ tumor in Malawi is feasible and efficacious. Pediatric Blood and Cancer 2009, 53(4); 584-589.
[9]	Tournade MF., Com-Nougue C., de Kraker J et a.. Optimal duration of pre-operative therapy in unilateral and non-metastatic Wilms’ tumour in children older than 6 months: results of the ninth International Society of Pediatric Oncology Wilms’ tumour trial and study. J.Clin Oncology 2001; 19, p 488-500.
[10]	Goorin AM., Borrow KM., Goldman A et al. Congestive heart failure due to Adriamycin cardiotoxicity: Its natural history in children. Cancer 47:2810, 1981.
[11]	Macharia WM’; Childhood cancers in a referral hospital in Kenya: a review. Journal: East Afr Med J. 1996 Oct;73(10):647-50.
[12]	Abdallah FK, Macharia WM Clinical presentation and treatment outcome in children with nephroblastoma in Kenya. East Afr Med J. 2001 Jul;78(7 Suppl): S43-7.
[13]	Kitonyi GW1, Macharia WM, Mwanda OW, Pamnani R.; Clinico-pathologic characteristics and treatment outcomes in children with neuroblastoma at the Kenyatta National Hospital, Nairobi. East Afr Med J. 2009 Dec;86(12 Suppl): S39-46.